Search

Your search keyword '"Hideshima, T"' showing total 719 results

Search Constraints

Start Over You searched for: Author "Hideshima, T" Remove constraint Author: "Hideshima, T"
719 results on '"Hideshima, T"'

Search Results

55. Protein arginine methyltransferase 5 has prognostic relevance and is a druggable target in multiple myeloma

61. TARGETING ANGIOGENESIS VIA A C-MYC/HIF-1 alpha-DEPENDENT PATHWAY IN MM

65. Targeting PKC informs in MM by enzastaurin (LY317615.HCL)

66. C-jun and C-ABL in human multiple myeloma cell death

76. Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma

77. Protein arginine methyltransferase 5 has prognostic relevance and is a druggable target in multiple myeloma

78. Identification and characterization of HLA-A24-specific XBP1, CD138 (Syndecan-1) and CS1 (SLAMF7) peptides inducing antigens-specific memory cytotoxic T lymphocytes targeting multiple myeloma

80. HMG-CoA inhibitors (statins) induce growth arrest, apoptosis of multiple myeloma (MM) and Waldenstrom's macroglobulinemia (WM) cells and enhance their sensitivity to conventional or novel therapies. Molecular profiling of HMG-CoA inhibition in MM/WM and framework for translation to therapeutic application

82. Histone deacetylase 3 as a novel therapeutic target in multiple myeloma

85. Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma

86. The effect of selective inhibition of HDAC6 with ACY1215 on bortezomib activity in multiple myeloma (MM).

88. MLN-8237

90. B281 Ciliary Proteins and Hedgehog Pathway in Multiple Myeloma

91. B026 CS1 Promotes Multiple Myeloma Cell Adhesion, Clonogenic Growth, and Tumorigenicity via c-Maf Mediation

92. A349 Phase I/II Trial of Perifosine + Bortezomib in Rel/Ref MM Patients Previously Treated with Bortezomib

93. B483 A Novel Small-Molecule Inhibitor RGB 286638 Induces Apoptosis and Necrosis in Multiple Myeloma

94. B540 The Effect of Insulin-Like Growth Factor-1 in Waldenström Macroglobulinemia

95. B203 A New Anti-Dkk-1 Antibody Targeting Myeloma Bone Disease

96. A224 Lenalidomide, Bortezomib, and Dexamethasone Has Notable Activity in High-Risk First-Line Myeloma

99. B469 Unraveling the Synergism of Nab-Rapamycin and Perifosine Combination in Multiple Myeloma

Catalog

Books, media, physical & digital resources